These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 15306145

  • 1. Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study.
    Lundt L.
    J Affect Disord; 2004 Aug; 81(2):173-8. PubMed ID: 15306145
    [Abstract] [Full Text] [Related]

  • 2. Modafinil in treatment of fatigue in multiple sclerosis. Results of an open-label study.
    Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM.
    J Neurol; 2002 Aug; 249(8):983-7. PubMed ID: 12195441
    [Abstract] [Full Text] [Related]

  • 3. Escitalopram in seasonal affective disorder: results of an open trial.
    Pjrek E, Winkler D, Stastny J, Praschak-Rieder N, Willeit M, Kasper S.
    Pharmacopsychiatry; 2007 Jan; 40(1):20-4. PubMed ID: 17327956
    [Abstract] [Full Text] [Related]

  • 4. Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepiness.
    Fava M, Thase ME, DeBattista C, Doghramji K, Arora S, Hughes RJ.
    Ann Clin Psychiatry; 2007 Jan; 19(3):153-9. PubMed ID: 17729016
    [Abstract] [Full Text] [Related]

  • 5. Treatment of seasonal affective disorder with duloxetine: an open-label study.
    Pjrek E, Willeit M, Praschak-Rieder N, Konstantinidis A, Semlitsch HV, Kasper S, Winkler D.
    Pharmacopsychiatry; 2008 May; 41(3):100-5. PubMed ID: 18484551
    [Abstract] [Full Text] [Related]

  • 6. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW, Earl CQ, Arora S.
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [Abstract] [Full Text] [Related]

  • 7. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial.
    Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D.
    Clin Ther; 2009 Aug; 31(8):1765-73. PubMed ID: 19808135
    [Abstract] [Full Text] [Related]

  • 8. Modafinil for atypical depression: effects of open-label and double-blind discontinuation treatment.
    Vaishnavi S, Gadde K, Alamy S, Zhang W, Connor K, Davidson JR.
    J Clin Psychopharmacol; 2006 Aug; 26(4):373-8. PubMed ID: 16855454
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J, Swanson JM, Wigal SB, Kratochvil CJ, Boellner SW, Earl CQ, Jiang J, Greenhill L.
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD, Harsh JR, Yang R, Rippon GA, Lankford DA.
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder.
    Fallu A, Richard C, Prinzo R, Binder C.
    Curr Med Res Opin; 2006 Dec; 22(12):2557-66. PubMed ID: 17166338
    [Abstract] [Full Text] [Related]

  • 19. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue.
    Ninan PT, Hassman HA, Glass SJ, McManus FC.
    J Clin Psychiatry; 2004 Mar; 65(3):414-20. PubMed ID: 15096082
    [Abstract] [Full Text] [Related]

  • 20. Open study of effects of alprazolam on seasonal affective disorder.
    Yamadera H, Okawa M, Takahashi K.
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):27-30. PubMed ID: 11235853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.